U.S. FDA today authorized Cognoa’s machine learning-based software to help diagnose autism spectrum disorder. The de novo authorization from FDA covers the use of the Cognoa ASD Diagnosis Aid with children 18 months through 5 years of age with potential ASD symptoms. Palo Alto, Calif.–based Cognoa has touted the software as a way to do away […]
